Home
Longitude Capital Partners IV reported a 4.9% stake in Zenas BioPharma ZBIO · 2,631,522 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 4.9%
- Last report
- No earlier report
- Shares held
- 2,631,522 sh
- Class
- Common Stock, $0.0001 par value per share
- Stock
- Zenas BioPharma ZBIO
- Event date
- 25/10/09
- Filed
- 25/10/14
4.9% stake · below 5%
Zenas BioPharma trades, last 26 weeks
What else happened in Zenas BioPharma around then
Filed or reported within 30 days of the trade day · 25/09/09~25/11/08Longitude Capital Partners IV's other 5% stake reports
- Longitude Capital Partners IV
5% stakeCG Oncology
5% stakeCG Oncology
CGON
6% stake
4,662,268 sh
6% stake
Filed 25/09/18
